New Covid pill: it’s time to place orders to be first on the list
Last year, many countries were slow in placing orders to get the vaccines against Covid from Pfizer, Moderna or Astra-Zeneca. This, of course, caused ...
Today's Focus of Attention
Share:
Listens: 13
About
Podcast with a variety of topics such as Technology, Science, Finance, Business, Economy as well as interviews with prominent personalities and experts in different areas.
One last shot - WHO experts to investigate the origins of Covid-19
Twenty-six scientists, from a wide range of scientific disciplines, will be involved in making a new global framework for emerging pathogens of epidem...
Hundreds of billions lost in Afghanistan
For over 20 years, the US ran hundreds of projects in Afghanistan through private contractors with little oversight. Many of them concluded successful...
Delta and misinformation have changed the course of the pandemic
The arrival of the Delta variant has shifted the course of the pandemic since it’s more transmissible than the previous variants and has become the do...
Pill against Covid-19 can reduce risk of hospitalisation
This is an experimental drug, but the clinical trials were positive and suggest that it reduces the risk of hospitalisation by 50%. The pill: “Molnupi...
Amnesty International: Vaccine inequity is a human rights crisis
Amnesty International published a report saying that vaccine developers have monopolised intellectual property, blocked technology transfers, and lobb...
Another dark stain on the chaotic withdrawal from Afghanistan: US admits Kabul drone strike killed innocent civilians
The 20-year war against ‘terror’ the US fought in Afghanistan has a new sombre chapter. Two days before the deadline for American troops to evacuate, ...
Which offers the best protection: a Covid infection or vaccines?
Natural immunity provides long-lasting and strong protection against Covid-19 but…which offers the best protection: a Covid infection or vaccines? In ...
FDA approves Covid-19 booster jabs for people over 65 and at-risk population
The Food and Drug Administration panel of advisers rejected Pfizer’s proposal to the widespread distribution of booster shots. This influential panel ...
Covid-19 vaccine boosters are not needed, say scientists
At this stage of the pandemic, vaccine booster shots are not needed for the general population. This is according to a group of international scient...